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Abstract
Background: Augmented renal clearance (ARC) of circulating solutes and drugs has been recently often reported
in intensive care unit (ICU) patients. However, only few studies on ARC have been reported in Japan. The aims of
this pilot study were to determine the prevalence and risk factors for ARC in Japanese ICU patients with normal
serum creatinine levels and to evaluate the association between ARC and estimated glomerular filtration rate (eGFR)
calculated using the Japanese equation.
Methods: We conducted a prospective observational study from May 2015 to April 2016 at the emergency ICU of a
tertiary university hospital; 111 patients were enrolled (mean age, 67 years; interquartile range, 53–77 years). We
measured 8-h creatinine clearance (CLCR) within 24 h after admission, and ARC was defined as body surface area-
adjusted CLCR ≥ 130 mL/min/1.73 m
2. Multiple logistic regression analysis was performed to identify the risk factors
for ARC. Moreover, a receiver operating curve (ROC) analysis, including area under the receiver operating curve
(AUROC) was performed to examine eGFR accuracy and other significant variables in predicting ARC.
Results: In total, 43 patients (38.7 %) manifested ARC. Multiple logistic regression analysis was performed for age,
body weight, body height, history of diabetes mellitus, Acute Physiology and Chronic Health Evaluation II scores,
admission categories of post-operative patients without sepsis and trauma, and serum albumin, and only age was
identified as an independent risk factor for ARC (odds ratio, 0.95; 95 % confidence interval [CI], 0.91–0.98). Moreover,
the AUROC of ARC for age and eGFR was 0.81 (95 % CI, 0.72–0.89) and 0.81 (95 % CI, 0.73–0.89), respectively. The
optimal cutoff values for detecting ARC were age and eGFR of ≤63 years (sensitivity, 72.1 %; specificity, 82.4 %) and
≥76 mL/min/1.73 m2 (sensitivity, 81.4 %; specificity, 72.1 %), respectively.
Conclusions: ARC is common in Japanese ICU patients, and age was an independent risk factor for ARC. In
addition, age and eGFR calculated using the Japanese equation were suggested to be useful screening tools for
identifying Japanese patients with ARC.
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Background
Clinicians often modify drug prescriptions to a patient’s
glomerular filtration rate (GFR) because renal clearance
influences the pharmacokinetics of many commonly
prescribed agents [1]. Intensive care unit (ICU) patients
in a critical condition with severe morbidity sometimes
experience acute kidney injury (AKI) [2]. Clinicians
usually reduce drug doses to prevent drug toxicity be-
cause drug elimination is impaired in these patients [3].
In contrast, recent studies [1, 4] reported that the
phenomenon of increased renal blood flow due to an in-
creased cardiac output might lead to an augmented
renal clearance (ARC) of circulating solutes and drugs.
Although creatinine clearance (CLCR) is not a gold
standard measurement of GFR (such as inulin clear-
ance), a close correlation was found between the ARC
phenomenon and CLCR [5, 6], and ARC phenomenon is
characterized by CLCR ≥ 130 mL/min/1.73 m
2 [7]. ARC
is potentially related to insufficient treatment and poor
prognosis due to sub-therapeutic drug concentrations
particularly in critically ill patients [5, 6, 8, 9]; therefore,
ARC should be recognized in the ICU setting. However,
ARC may occur in patients with normal serum creatin-
ine (SCr) level [10, 11], and CLCR measurement is not
routinely performed in the ICU for daily treatments; the
accurate recognition of this phenomenon is difficult for
clinicians. For this reason, previous studies [12, 13] veri-
fied the correlation between ARC and estimated glom-
erular filtration rate (eGFR), which was calculated using
various formulas (such as Cockcroft–Gault equation
[14], Modification of Diet in Renal Disease [MDRD]
Study equation [15], Robert equation [16], and the
Chronic Kidney Disease Epidemiology Collaboration
[CKD-EPI] equation [17]) used in clinical practice
worldwide. In contrast, few studies and discussions regard-
ing ARC in Japan have been reported. To the best of our
knowledge, no study has been reported on the correlation
between ARC and eGFR calculated using the Japanese
eGFR equation, which is used throughout Japan [18]. The
aims of this pilot study were to determine the prevalence
and risk factors for ARC in Japanese ICU patients with nor-
mal SCr levels and to evaluate the association between ARC
and eGFR calculated using the Japanese equation.
Methods
Setting
This prospective, single-center, observational study was
conducted in a 32-bed emergency ICU of the Fukuoka
University Hospital, a tertiary hospital in Japan, from
May 2015 to April 2016. This study was approved by the
institutional ethics committee (number 15-4-07), and in-
formed consent was obtained from all participants or a
surrogate decision maker.
Study population
Patients who were expected to stay more than 24 h, with no
evidence of renal impairment (admission SCr > 1.1 mg/dL)
and no history of renal replacement therapy were enrolled.
The exclusion criteria for study admission were as follows:
age < 18 years, pregnancy, suspicion of rhabdomyolysis or
admission SCr kinase concentration >5000 IU/L, diagnosis
of cardiopulmonary arrest on admission, and developing
AKI as defined by the Risk, Injury, Failure, Loss of kidney
function, End-Stage Kidney Disease criteria [19]. Moreover,
patients treated without both an intra-arterial cannula, and
an indwelling urinary catheter (IDC) were also excluded. In
total, 111 patients were enrolled.
Data collection and definition
Demographic and laboratory data, including age, sex, body
measurements, cumulative number of systemic inflamma-
tory response syndrome (SIRS) [20], medical history of
diabetes mellitus, and the levels of serum albumin and
blood glucose were recorded on admission. Information
regarding ventilation variables, vasopressor or inotrope
administration, diuretic use, and admission diagnosis was
recorded after the first 24 h. In addition, the patients were
divided into the following four groups based on the diag-
nosis on admission: sepsis, post-operative patients without
sepsis, trauma (divided based on severity, injury severity
score [ISS] ≥ 16 or ISS < 16), and others.
Physiological and laboratory data needed to calculate
the Acute Physiology and Chronic Health Evaluation
(APACHE) II scores and Sequential Organ Failure As-
sessment (SOFA) scores were reported as the worst
value within 24 h after hospital admission. The mean
urine output (mL/kg/h) and fluid balance were recorded
during the first hospital day. Because previous reports
[21, 22] suggest that renal function can be measured
most accurately using an 8-, 12-, or 24-h CLCR collec-
tion, the 8-h CLCR was measured in this study. Urinary
volume was measured from the IDC within the first
24 h of admission, and the blood sampling for eGFR and
CLCR measurement were performed simultaneously after
the completion of the 8-h CLCR collection. The urinary
creatinine (UCr) level and the SCr were determined by la-
boratory analysis by using an enzymatic method.
We calculated eGFR by using a three-variable Japanese
equation [18].
For males: eGFR (mL/min/1.73 m2) = 194 × [SCr(mg/
dL)]‐ 1.094 × age‐ 0.287
For females: eGFR (mL/min/1.73 m2) = 194 ×
[SCr(mg/dL)]
‐ 1.094 × age‐ 0.287 × 0.739
The CLCR was calculated by using the standard
formula. CLCR values were subsequently normalized to a
body surface area (BSA) of 1.73 m2 as per convention.
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CLCR and BSA were calculated based on the following
formulae:
CLCR mL=min=1:73 m2ð Þ ¼ ½UCr mg=dLð Þ=SCr mg=dLð Þ
 8‐h urinary volume mLð Þ=480
 1:73=BSA m2 
BSA m2
  ¼ 0:007184  height cmð Þ½ 0:725
 weight kgð Þ½ 0:425
Data collection began immediately after obtaining
an informed consent and was discontinued at ICU
discharge or death, development of severe renal im-
pairment (measured CLCR < 30 mL/min/1.73 m
2), ini-
tiation of renal replacement therapy, intra-arterial
cannula or IDC removal, and patient consent with-
drawal. ARC was defined as an 8-h CLCR ≥ 130 mL/
min/1.73 m2 [7].
Statistical analysis
Continuous data were expressed as mean (standard devi-
ation [SD]) or median (interquartile range [IQR]), and
categorical data as percentage. The Student t test or
Mann–Whitney U test and chi-square test were used for
continuous and categorical data, respectively. Multiple
logistic regression analysis was performed to identify the
risk factors for ARC. Because serum albumin levels and
diabetic conditions were shown to influence tubular cre-
atinine secretion [23, 24], these factors were included as
explanatory variables in multivariate analysis. Further-
more, the explanatory variables in this analysis were also
determined from any variables with a p value of less
than 0.05 in the univariate analysis. The odds ratio (OR)
and 95 % confidence interval (CI) were calculated. The
correlations between the measured CLCR and eGFR were
assessed by using Spearman correlation coefficient (r),
and the Bland and Altman method [25] was used to
Table 1 Demographic and laboratory data
Variable All patients (n = 111) Patients with ARC (n = 43) Patients without ARC (n = 68) p valuea
Age, median (IQR) 67 (53–77) 55 (38–65) 72 (66–79) <0.05
Male sex, n (%) 62 (55.9) 22 (51.2) 40 (58.8) 0.44
Body weight (kg), median (IQR) 56.3 (49.9–68.2) 60.7 (52.8–74.1) 53.2 (47.9–62.5) <0.05
Body height (m), mean (SD) 1.61 (0.1) 1.64 (0.1) 1.59 (0.09) <0.05
Body mass index (kg/m2), mean (SD) 22.7 (3.88) 23.6 (3.75) 22.1 (3.87) <0.05
Body surface area (m2), median (IQR) 1.57 (1.46–1.79) 1.67 (1.54–1.85) 1.55 (1.41–1.69) <0.05
Diabetes mellitus, n (%) 22 (19.8) 5 (11.6) 17 (25) 0.09
Mechanical ventilation, n (%) 21 (18.9) 6 (14) 15 (22.4) 0.33
Vasopressor, n (%) 2 (1.8) 0 2 (2.9) 0.52
Inotrope, n (%) 8 (7.2) 2 (4.6) 6 (8.8) 0.48
Diuretic therapy, n (%) 6 (5.4) 1 (2.3) 5 (7.4) 0.4
APACHE II scores, median (IQR) 14 (10.5–19.5) 13 (8.5–15.5) 16 (11.8–23) <0.05
SOFA scores, median (IQR) 3 (2–5) 3 (2–4) 3 (2–5) 0.33
The cumulative number of SIRS, median (IQR) 1 (1–2) 1 (1–2) 1 (1–2) 0.96
Admission category, n (%)
Sepsisb 3 (2.7) 0 3 (4.4) 0.28
Post-operative patients without sepsis 25 (22.5) 4 (9.3) 21 (30.9) <0.05
Trauma 32 (28.8) 20 (46.5) 12 (17.6) <0.05
ISS≥ 16 19 10 9
ISS < 16 13 10 3
Others 51 (45.9) 19 (44.2) 32 (47.1) 0.85
Serum albumin (g/dL), median (IQR) 3.9 (3.4–4.3) 4.2 (3.7–4.4) 3.8 (3.2–4.2) <0.05
Blood glucose (mg/dL), median (IQR) 136 (115–160) 128 (111–150) 141 (118–168) 0.12
Mean urine output (mL/kg/h), median (IQR) 0.92 (0.64–1.36) 0.94 (0.7–1.4) 0.77 (0.6–1.35) 0.29
Fluid balance (mL), median (IQR) 739 (55.5–1290) 993 (−70–1460) 572 (81.3–1125) 0.33
ARC augmented renal clearance, IQR interquartile range, SD standard deviation, APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ
Failure Assessment, SIRS systemic inflammatory response syndrome, ISS injury severity score
aThe p values were evaluated by comparison between patients with and without ARC
bSepsis was diagnosed based on evidence of infection along with the presence of SIRS
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check the bias and limits of agreement between the mea-
sured CLCR and eGFR. Bias was defined as the mean dif-
ference between eGFR and measured CLCR. The 95 %
limits of agreement were calculated as the bias ±1.96
SD. Moreover, a receiver operating curve (ROC) analysis,
including the area under the receiver operating curve
(AUROC), was performed to examine the accuracy of
the eGFR and other significant variables in predicting
ARC. The ROC was plotted for each score by using sen-
sitivity and specificity values for true prediction of ARC
across the entire range of potential cutoff values to pre-
dict ARC. The AUROC was constructed and compared
as described in a previous report [26]. All tests were
two-tailed, and a p value of <0.05 was considered statis-
tically significant.
All statistical analyses were performed by using the EZR
software program (Saitama Medical Center, Jichi Medical
University, Saitama, Japan) [27], which is a graphical user
interface for the R software program (The R Foundation
for Statistical Computing, Vienna, Austria). More pre-
cisely, it is a modified version of R commander, which was
designed to add statistical functions frequently used in
biostatistics.
Results
Baselines characteristics of study subjects
The characteristics of the enrolled patients are shown in
Table 1.
We enrolled 111 patients in this study (mean age,
67 years [IQR, 53–77 years], 55.9 % male). Of these, 43
patients (38.7 %) were identified as manifesting ARC. In
addition, ARC occurred more frequently in trauma pa-
tients (20/32, 62.5 %) and less frequently in post-operative
patients without sepsis (4/25, 16.0 %), in comparison with
the overall incidence of 38.7 % (43/111). The mean
APACHE II score was 14 (IQR, 10.5–19.5), and the mean
SOFA score was 3 (IQR, 2–5). Vasopressor and diuretic
therapies were administered to a few patients in this study.
Moreover, few patients had an admission diagnosis of
sepsis (2.7 %), and only 59.4 % (19/32) were categorized as
severe trauma patients (ISS ≥ 16).
Risk factors for ARC
The following variables were significantly different be-
tween patients with and without ARC: age, body weight,
Table 2 Multiple logistic regression analysis for augmented
renal clearance
Variables OR (95 % CI) p value
Age 0.95 (0.91–0.98) <0.05
Body weight 1.03 (0.98–1.09) 0.25
Body height 0.96 (0.89–1.02) 0.21
Diabetes mellitus 0.73 (0.20–2.73) 0.64
APACHE II scores 0.95 (0.88–1.03) 0.24
Post-operative patients without sepsis 0.28 (0.07–1.04) 0.06
Trauma 1.83 (0.60–5.59) 0.29
Serum albumin 1.36 (0.63–2.93) 0.44
OR odds ratio, CI confidence interval, APACHE Acute Physiology and Chronic
Health Evaluation
Fig. 1 Comparison of the estimated glomerular filtration rate (eGFR)
in patients with and without augmented renal clearance (ARC). The
eGFR in patients with ARC was significantly higher than that in
patients with ARC (p < 0.05) * p < 0.05
Fig. 2 Correlation between the measured creatinine clearance (CLCR)
and estimated glomerular filtration rate (eGFR). A statistically
significant correlation was recognized between the measured CLCR
and eGFR with Spearman coefficient of 0.75 (p < 0.05)
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body height, body mass index, BSA, APACHE II scores,
admission categories of post-operative patients without
sepsis and trauma, and serum albumin (all p < 0.05).
Multiple logistic regression analysis was performed for
eight variables (such as age, body weight, body height,
history of diabetes mellitus, APACHE II scores, admis-
sion categories of post-operative patients without sepsis
and trauma, and serum albumin), and the result showed
that only age is an independent risk factor for ARC (OR,
0.95; 95 % CI, 0.91–0.98) (Table 2).
Evaluation of eGFR calculated using the Japanese equation
Analysis to determine the correlation between ARC and
eGFR revealed that the eGFR of patients with ARC was
significantly higher than that of patients without ARC
(p < 0.05) (Fig. 1). Moreover, a statistically significant
correlation was found between measured CLCR and
eGFR, with a Spearman coefficient (r) of 0.75 (p < 0.05)
(Fig. 2). In contrast, the Bland–Altman plots showed
that the bias of the two variables was −46.1 mL/min/
1.73 m2, and the 95 % limits of agreement were −128.9
to 36.7 mL/min/1.73 m2.
Most parts of the eGFR tended to underestimate
CLCR. In addition, the difference between eGFR and
measured CLCR further increased when the kidney func-
tion of the patients improved (Fig. 3).
Prognostic value for ARC
We performed the ROC analysis to evaluate the prog-
nostic value of age and eGFR for ARC. The AUROC of
age and eGFR was 0.81 (95 % CI, 0.72–0.89) and 0.81
(95 % CI, 0.73–0.89), respectively. The optimal cutoff
value of each factor for ARC was age ≤63 years (sensitiv-
ity, 72.1 %; specificity, 82.4 %) and eGFR ≥ 76 mL/min/
1.73 m2 (sensitivity, 81.4 %; specificity, 72.1 %) (Table 3).
Discussion
To the best of our knowledge, this is the first study that
investigated ARC in Japanese adult ICU patients. Our
results demonstrate that approximately 40 % of patients
who were admitted to our ICU with normal SCr levels
on the first hospital day manifested ARC, which was
similar to a previous report [3]. Age was identified as an
independent risk factor for ARC in multivariate logistic
regression analysis in this study, and several previous
Fig. 3 Measures of agreement between the measured creatinine clearance (CLCR) and estimated glomerular filtration rate (eGFR). The solid line
indicates the mean of the difference between the results of the eGFR and measured CLCR. The dashed line shows the 95 % limits of agreement.
Most parts of eGFR tended to underestimate the CLCR. In addition, the difference between the eGFR and measured CLCR further increased when
the kidney function of the patients improved
Table 3 Augmented renal clearance prediction of age and estimated glomerular filtration rate using the receiver operating curves
AUROC 95 % CI Optimal cutoff values Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Age (years) 0.81 0.72–0.89 63 72.1 82.4 80.4 74.7
eGFR (mL/min/1.73 m2) 0.81 0.73–0.89 76 81.4 72.1 74.5 79.5
eGFR estimated glomerular filtration rate, AUROC area under the receiver operating curve, CI confidence interval, PPV positive predictive value, NPV negative
predictive value
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studies [3, 12] have also shown that ARC is more com-
mon in younger patients.
In contrast, no relationship was found between urine
output and ARC phenomenon, and the same trend on
fluid balance was also shown in this report. We demon-
strated that the ARC phenomenon was not simply related
to ongoing fluid loading, and a previous study supported
this statement [3]. Moreover, with regard to illness severity
score, patients with ARC had significantly lower APACHE
II scores on admission compared with patients without
ARC in the univariate analysis. In contrast, we did not ob-
serve the same trend in SOFA scores. The result of the
multivariate analysis showed that the different trends in
the two severity scores could have been due to the
influence of age. The APACHE II score evaluates the illness
severity of patients based on physiologic measurements,
age, and previous health status [28], whereas the SOFA
score was assessed by grading organ dysfunction, not by
age [29]. ARC was seen in the younger population; there-
fore, patients with ARC tend to obtain lower APACHE II
scores compared with those of patients without ARC.
Previous studies [12, 30] showed that multi-trauma was
a significant risk factor for ARC, but these findings were
different from our results. The difference in these findings
is likely related to the small sample of patients with severe
trauma (only 19 patients) in this single-center study.
The eGFR in this report, which was calculated by
using the Japanese equation, was significantly different
between patients with and without ARC, and the corre-
lations better represented the true relationship between
the measured CLCR and eGFR, with a Spearman coeffi-
cient (r) of more than 0.7. Although a better correlation
was recognized between these variables in this study,
eGFR could not detect patients with ARC accurately;
eGFR was not considered for ICU patients with severe
conditions that influenced renal function because eGFR
was principally designed for use in an ambulatory or
ward-based setting initially [31, 32]. Therefore, previous
reports [12, 13] showed that the derived values from sev-
eral formulae (Cockcroft–Gault and MDRD) signifi-
cantly underestimated the CLCR, and no eGFR formula
accurately identifies ARC in critically ill patients. How-
ever, given the better correlation between the measured
CLCR and eGFR calculated using the Japanese equation,
this study showed that eGFR might be a useful tool for
screening Japanese patients with ARC. Because eGFR
tended to underestimate the CLCR as shown in the
Bland–Altman plots, the eGFR cutoff values for screen-
ing ARC were ≥76 mL/min/1.73 m2, which was lower
than 130 mL/min/1.73 m2. In addition, age ≤63 years
could also be evaluated for screening simultaneously.
After screening patients with ARC, the CLCR should be
measured through urine collection formally for modify-
ing the drug dosage as necessary.
This study has some limitations. First, this was a
single-center study including a limited number of study
participants. Second, this study was not designed to as-
sess ARC after the second hospital day. Although ARC
on the first hospital day was strongly associated with
higher clearances over a few days, ARC occurring after
the second hospital day has been reported [3]. Third, the
gold standard for the assessment of renal function is
measurement of the urinary or plasma clearance of an
ideal filtration marker (such as inulin) [33], but this
measurement was not performed in this study. Fourth,
because we did not evaluate eGFR, which was calculated
by using various formulas (such as Cockcroft–Gault,
MDRD, Robert, and CKD-EPI) used worldwide, for iden-
tifying ARC in the present study, the best equation for
eGFR to identify Japanese patients with ARC is unclear.
Fifth, although the creatinine levels were determined by
an enzymatic method in the present study, the creatinine
levels were determined by other methods such as the
Jaffe method in a previous study, which was cited for the
present ARC definition. The creatinine levels in serum
and urine by the Jaffe method are higher than those by
the enzyme method, and CLCR values are affected by
these measurement methods [34]. Thus, ARC definition
might need to be changed based on the measurement
method for creatinine levels. Finally, because this report
is a pilot study for ARC in the Japanese population, a
validation of the predictive factors for ARC (such as age
and eGFR) was not performed. Therefore, further studies
are needed to address the limitations of this study.
Conclusions
This study showed that ARC appeared to be common in
Japanese ICU patients with normal SCr levels on the first
hospital day, and only age was an independent risk fac-
tor for ARC. In addition, not only age but also eGFR cal-
culated using the Japanese equation might be useful as a
screening tool for identifying Japanese patients with
ARC. Further multicentre studies are needed to obtain
precise data regarding ARC in the Japanese population.
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